Sinocelltech Group Limited

Shanghai Stock Exchange 688520.SS

Sinocelltech Group Limited Receivables for the year ending December 31, 2023: USD 63.16 M

Sinocelltech Group Limited Receivables is USD 63.16 M for the year ending December 31, 2023, a 62.15% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Sinocelltech Group Limited Receivables for the year ending December 31, 2022 was USD 38.95 M, a 203.32% change year over year.
Sinocelltech Group Limited Receivables for the year ending December 31, 2021 was USD 12.84 M, a 917.40% change year over year.
Sinocelltech Group Limited Receivables for the year ending December 31, 2020 was USD 1.26 M, a 343.78% change year over year.
Sinocelltech Group Limited Receivables for the year ending December 31, 2019 was USD 284.41 K, a -34.73% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Shanghai Stock Exchange: 688520.SS

Sinocelltech Group Limited

CEO	Dr. Liangzhi Xie Ph.D.
IPO Date	June 22, 2020
Location	China
Headquarters	No. 31 Kechuang 7th Street
Employees	2,313
Sector	Healthcare
Industries Biotechnology 3D Printing

Description

Sinocelltech Group Limited, a biotech company, focuses on the development of technologies for the development and manufacturing of recombinant proteins, monoclonal antibodies, and vaccines in China. The company is based in Beijing, China.

Key trends

Past 5 years